52 results  1 of 3 

1 Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting
Shinae Yu, Hee Jae Huh, Kyo Won Lee, Jae Berm Park, Sung-Joo Kim, Wooseong Huh, Hye Ryoun Jang, Ghee Young Kwon, Hyung Hwan Moon, Eun-Suk Kang
Ann Lab Med.2020;40(5):398-408.   Published online 2020 September 1     DOI: http://dx.doi.org/10.3343/alm.2020.40.5.398
2 Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
Inho Kim, Chan Soon Park, Hae-Young Lee
Korean Circ J.2019;49(7):615-626.   Published online 2019 March 5     DOI: http://dx.doi.org/10.4070/kcj.2018.0379
3 Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
Seung Ah Cha, Byung Mun Park, Suhn Hee Kim
Korean J Physiol Pharmacol.2018;22(4):447-456.   Published online 2018 June 25     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.4.447
4 Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients
Ji Won Min, Hyeyoung Lee, Bum Soon Choi, Cheol Whee Park, Chul Woo Yang, Yong-Soo Kim, Yeong Jin Choi, Eun-Jee Oh, Byung Ha Chung
Ann Lab Med.2018;38(5):450-457.   Published online 2018 May 23     DOI: http://dx.doi.org/10.3343/alm.2018.38.5.450
5 Silencing MR-1 attenuates atherosclerosis in ApoE−/− mice induced by angiotensin II through FAK-Akt–mTOR-NF-kappaB signaling pathway
Yixi Chen, Jianping Cao, Qihui Zhao, Haiyong Luo, Yiguang Wang, Wenjian Dai
Korean J Physiol Pharmacol.2018;22(2):127-134.   Published online 2018 February 23     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.2.127
6 Comparative effects of angiotensin II and angiotensin-(4-8) on blood pressure and ANP secretion in rats
Hoang Thi Ai Phuong, Lamei Yu, Byung Mun Park, Suhn Hee Kim
Korean J Physiol Pharmacol.2017;21(6):667-674.   Published online 2017 October 30     DOI: http://dx.doi.org/10.4196/kjpp.2017.21.6.667
7 Expression of Class I and Class II a/b Histone Deacetylase is Dysregulated in Hypertensive Animal Models
Hae Jin Kee, Gwi Ran Kim, Ming Quan Lin, Sin Young Choi, Yuhee Ryu, Li Jin, Zhe Hao Piao, Myung Ho Jeong
Korean Circ J.2017;47(3):392-400.   Published online 2017 May 12     DOI: http://dx.doi.org/10.4070/kcj.2016.0266
8 Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model
Jong-Il Choi, Jae Seung Jung, Min Kyung Kim, Jaemin Sim, Jin Seok Kim, Hong Euy Lim, Sang Weon Park, Young-Hoon Kim
Korean Circ J.2016;46(3):335-342.   Published online 2016 April 26     DOI: http://dx.doi.org/10.4070/kcj.2016.46.3.335
9 Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase
Tae-Sun Ha, Hye-Young Park, Su-Bin Seong, Hee-Yul Ahn
J Korean Med Sci.2016;31(4):535-541.   Published online 2016 March 2     DOI: http://dx.doi.org/10.3346/jkms.2016.31.4.535
10 Protective effects of kaempferol against cardiac sinus node dysfunction via CaMKII deoxidization
Minae An, Minsuk Kim
Anat Cell Biol.2015;48(4):235-243.   Published online 2015 December 21     DOI: http://dx.doi.org/10.5115/acb.2015.48.4.235
11 The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
Juhan Lee, Beom Seok Kim, Yongjung Park, Jae Geun Lee, Beom Jin Lim, Hyeon Joo Jeong, Yu Seun Kim, Kyu Ha Huh
Yonsei Med J.2015;56(6):1638-1642.   Published online 2015 September 25     DOI: http://dx.doi.org/10.3349/ymj.2015.56.6.1638
12 Trichostatin A Modulates Angiotensin II-induced Vasoconstriction and Blood Pressure Via Inhibition of p66shc Activation
Gun Kang, Yu Ran Lee, Hee Kyoung Joo, Myoung Soo Park, Cuk-Seong Kim, Sunga Choi, Byeong Hwa Jeon
Korean J Physiol Pharmacol.2015;19(5):467-472.   Published online 2015 August 20     DOI: http://dx.doi.org/10.4196/kjpp.2015.19.5.467
13 The Angiotensin II-Stimulated Phospholipase Activity in Adrenal Glomerulose Cells of Diabetic Rats
Yeon-Ah Sung
Ewha Med J.1997;20(1):13-21.   Published online 2015 July 24     DOI: http://dx.doi.org/10.12771/emj.1997.20.1.13
14 Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
Hyeyoung Lee, Ji-Il Kim, In-Sung Moon, Byung Ha Chung, Chul-Woo Yang, Yonggoo Kim, Kyungja Han, Eun-Jee Oh
Ann Lab Med.2015;35(3):314-320.   Published online 2015 April 1     DOI: http://dx.doi.org/10.3343/alm.2015.35.3.314
15 Comparison of Inhibitory Effects between Enalapril and Losartan on Adrenal Catecholamine Secretion
Hyo-Jeong Lim, Young-Youp Koh, Dong-Yoon Lim
J Korean Soc Hypertens.2014;20(2):51-67.   Published online 2014 June 13     DOI: http://dx.doi.org/10.5646/jksh.2014.20.2.51
16 Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
Da-Rae Kim, Joo-Hee Cho, Won-Seok Jang, Jin-Sug Kim, Kyung-Hwan Jeong, Tae-Won Lee, Chun-Gyoo Ihm
Electrolyte Blood Press.2013;11(2):56-59.   Published online 2013 December 31     DOI: http://dx.doi.org/10.5049/EBP.2013.11.2.56
17 Influence of PD 123319 (AT2-Receptor Antagonist) on Catecholamine Secretion in the Perfused Rat Adrenal Medulla
Soon-Pyo Hong, Bhandary Bidur, Mee-Sung Choi, Young-Hwan Seo, Dong-Yoon Lim
J Korean Soc Hypertens.2013;19(1):23-38.   Published online 2013 March 10     DOI: http://dx.doi.org/10.5646/jksh.2013.19.1.23
18 Altered Regulation of Endothelin, Atrial Natriuretic Peptide, and Nitric Oxide Systems in Angiotensin II-induced Hypertension
Eun Hui Bae, Chang Seong Kim, Joon Seok Choi, Seong Kwon Ma, Jong Un Lee, Soo Wan Kim
J Korean Soc Hypertens.2012;18(4):146-153.   Published online 2012 December 31     DOI: http://dx.doi.org/10.5646/jksh.2012.18.4.146
19 The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications
Shuji Sasaki, Toyoshi Inoguchi
Diabetes Metab J.2012;36(4):255-261.   Published online 2012 August 20     DOI: http://dx.doi.org/10.4093/dmj.2012.36.4.255
20 Role of Inflammation in the Pathogenesis of Arterial Stiffness
Sungha Park, Edward G. Lakatta
Yonsei Med J.2012;53(2):258-261.   Published online 2012 January 30     DOI: http://dx.doi.org/10.3349/ymj.2012.53.2.258

 1 of 3